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This multi-author small volume represents
an excellent and much needed critical review
of clinical-trial research in many areas of
cancer in man. Most of the recognized
experts in their particular fields are contri-
butors, and it is especially pleasing that
chemotherapists appear to be as critical of
their own discipline as irradiation and
surgical oncologists have been for many
years. This volume encompasses the major
areas of chemotherapy in human cancer,
and it is perhaps appropriate that the
first chapter should be devoted to acute
lymphocytic leukaemia in children. The work
of St Jude's Children's Hospital is rightly
given pride of place. It is with this disease
and with the meticulous work from this
particular centre that much good clinical
trial research in cancer has subsequently
stemmed.
It is invidious to single out other chapters,
but that on soft-tissue sarcoma in adults
deserves special mention for its very critical
assessment of many of the chemotherapy
studies published to date. Other chapters
include the non-acute leukaemias, the lym-
phomas and paediatric tumours. The other
common tumours in adults are well represen-
ted. For any practising clinical oncologist,
this volume represents not only a lesson in
critical evaluation of clinical trials, but also
provides a comprehensive bibliography at
the end of each chapter. There is no doubt
in this reviewer's mind that this book should
be made compulsory reading for any trainee
in Medical Oncology, and trainees in other
cancer-therapeutic disciplines might also
benefit from its perusal.
H. BUSH
Biological Oxidation of Nitrogen. Ed.
J. W. GORROD (1978) Amsterdam: Else-
vier/North-Holland. 502 pp. US$62.25.
This book reports the Proceedings of the
2nd International Symposium on the subject
held at Chelsea College, London in September
1977. It contains 62 papers plus a report of a
round-table discussion. No fewer than 17 of
the articles come from Chelsea College and
the editor of the book is a co-author of
9 of them. The general subject is, of course,
of considerable interest to workers in the
field of chemical carcinogenesis. Specifically,
however, there are few articles which are
of direct relevance. Amongst the relevant
articles, work is described on the metabolism
of dimethylnitrosamine and on the detoxifi-
cation of N-hydroxy-2-fluorenylacetamide.
There is also some limited information on the
enzymology of N-oxidation. A large number
of the articles in this book contain detailed
descriptions of the metabolism of specific
compounds. These papers will certainly be of
interest to workers studying these and related
substances, but they are unlikely to have a
wide appeal. The book is very high-priced
and most of its contents have been or will be
published in the journal literature. Libra-
rians should not, therefore, feel any compul-
sion to purchase it.
B. R. RABIN
Tactics and Strategy in Cancer Treat-
ment. Ed. G. MATHEI (1977) Berlin, New
York: Springer-Verlag. 219 pp. $31.30.
This book reports the annual meeting of
the E.O.R.T.C. held in June 1976, and repre-
sents a varied collection of clinical-trial
reports. Despite the title, very few of the
contributors attempt to develop general
strategies for further study within the
framework of particular malignant diseases.
Manyofthereports represent simply results of
clinical trials, some of which have been pub-
lished elsewhere. It is also a pity that at the
time ofthis reviewsome ofthestudies are con-
siderably out-of-date and the general useful-
ness ofthisvolumein 1978 maybe questioned.
Nonetheless, there are some excellent reviews,
including that by Lemerle on the manage-
ment of Wilms' tumour and an interesting
if not conclusive review by Klein on the
management of patients with polycythemia
vera. At the price of $31.30 this volume would
seem to be a luxury for all but those who
wish to complete their collection in this
'Recent Results in Cancer Research' series.
H. BUSH